Navigation Links
Breast Cancer Radiation Before 1984 Tied to Heart Disease
Date:1/17/2011

MONDAY, Jan. 17 (HealthDay News) -- Among long-term breast cancer survivors, those who were treated with radiotherapy before 1984 appear to face much higher rates of death due to heart disease, new French-Swiss research indicates.

The study results, published in the Jan. 25 issue of the Journal of the American College of Cardiology, "confirm that radiotherapy for breast cancer, such as that practiced until the mid-1980s, increased the long-term risk of death from cardiac disease," the authors said in a journal news release.

In the study, the researchers tracked nearly 4,500 women who had been treated for breast cancer between 1954 and 1984 at the Institut Gustave Roussy (IGR) in Villejuif, France.

All of the women in the study had survived their initial breast cancer diagnosis for a minimum of five years, and the study tracked such survivors for an average of 28 years, making it one of the few investigations to explore the long-term side effects of breast cancer treatment.

The analysis, based on data from medical records and national registries, found that about two-thirds of the women had been treated with radiation during the study time-frame, according to study author Florent de Vathaire of the Radiation Epidemiology Group at INSERM and the IGR, and colleagues.

The cause of death could be determined for the vast majority of the 2,637 breast cancer survivors who ultimately died before the age of 95. The investigators found that 421 died from cardiovascular disease, including 236 from cardiac diseases and 185 from vascular diseases.

The team further established that the risk of dying from heart disease was 1.76 times higher among those exposed to radiation therapy compared with those who were not exposed. In addition, the risk of dying from cardiovascular diseases as a whole was 1.56 greater among this group.

Not all types of exposure to radiation therapy appeared to have the same negative consequences for heart health. Women whose tumor was on the left side (and were therefore exposed to radiotherapy on the left side) faced a higher risk for cardiac disease than those whose tumor was located on the right side, they found.

In an editorial accompanying the study, Dr. Ronald M. Witteles, of the division of cardiovascular medicine at the Stanford University School of Medicine, described the new analysis as both "convincing" and "important." He also cautioned that despite technological advances, radiation dosages used today among breast cancer patients "remain substantial." Physicians, he noted, should stay vigilant with respect to the potential harm such exposure can cause.

More information

For more on breast cancer and radiation therapy, visit BreastCancer.org.

-- Alan Mozes

SOURCE: Journal of the American College of Cardiology, news release, Jan. 17, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Finds Racial Disparity in Breast Cancer Outcomes
2. Study provides molecular rationale for combining targeted agents to treat breast cancer
3. Preoperative breast MRI suggests high cancer yield
4. Quality of life measures in breast cancer clinical trials
5. Quality of Life Key Measure in Breast Cancer Clinical Trials
6. Teens Breast-fed as Infants Have Stronger Leg Muscles
7. Breast Cancer Outcome: Your Doctor Matters
8. High dietary fat, cholesterol linked to increased risk of breast cancer
9. Experimental Drug Helps Fight Aggressive Breast Cancer: Report
10. More Evidence Links Avastin to Heart Failure in Breast Cancer Patients
11. Peptide delivers 1-2 punch to breast cancer in pre-clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Radiation Before 1984 Tied to Heart Disease
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar with ... new study from the Osteoarthritis Initiative shows that certain people who experience ... this in advance may give doctors the opportunity to treat patients before the problem ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from ... May 30th and 31st at The Four Seasons Hotel Boston. , The ... life sciences, offering exclusive access to key decision makers who influence deal making ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 2017  A new tight-tolerance microextrusion medical tubing ... materials, is being launched by Natvar, a Tekni-Plex ... in recent years to service a wide variety ... More expensive materials such as glass and fluoropolymers ... to their ability to consistently hold tolerances. This ...
(Date:5/3/2017)... 2017  Kalorama Information notes that transplant diagnostics ... year and this is projected to continue to ... (HSCT) or bone marrow transplants require histocompatibility between ... for this task. This according to a new ... The various PCR-based methodologies, Sanger sequencing and NGS ...
(Date:5/2/2017)... NEW YORK and LONDON ... distributor of market intelligence, MarketResearch.com is pleased to announce ... Consulting AB that allows for the marketing and ... market analyses through the MarketResearch.com website. The ... access to complete product descriptions and tables of contents ...
Breaking Medicine Technology: